Peter Atadja

Peter Atadja" alt="Peter Atadja" itemprop="image">

Company: K36 Therapeutics

Job title: Scientific Co-Founder


PANEL DISCUSSION: 2022 & Beyond: Where Do We See the Epigenetics Drug Discovery & Development Landscape Over the Next 5 Years? 9:00 am

Outlining the successes of the past year in epigenetics drug development Reviewing novel approaches to targeting epigenetic regulators to diversify your pipeline Shedding light on the need to explore novel translational applications for epigenetic drugs to enter new indicationsRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.